NO20006542D0 - N-fenyl-N'-fenylpropylpiperazinderivater og fremgangsmåte for fremstilling derav - Google Patents

N-fenyl-N'-fenylpropylpiperazinderivater og fremgangsmåte for fremstilling derav

Info

Publication number
NO20006542D0
NO20006542D0 NO20006542A NO20006542A NO20006542D0 NO 20006542 D0 NO20006542 D0 NO 20006542D0 NO 20006542 A NO20006542 A NO 20006542A NO 20006542 A NO20006542 A NO 20006542A NO 20006542 D0 NO20006542 D0 NO 20006542D0
Authority
NO
Norway
Prior art keywords
phenylpropylpiperazine
phenyl
derivatives
preparation
phenylpropylpiperazine derivatives
Prior art date
Application number
NO20006542A
Other languages
English (en)
Other versions
NO20006542L (no
Inventor
Hiroki Sato
Eiichi Nagano
Jun Chikazawa
Mineo Takei
Raita Higashino
Original Assignee
Zeria Pharmaceutical Company L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeria Pharmaceutical Company L filed Critical Zeria Pharmaceutical Company L
Publication of NO20006542D0 publication Critical patent/NO20006542D0/no
Publication of NO20006542L publication Critical patent/NO20006542L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20006542A 1998-06-30 2000-12-21 N-fenyl-N'-fenylpropylpiperazinderivater og fremgangsmåte for fremstilling derav NO20006542L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19814898 1998-06-30
PCT/JP1999/003448 WO2000000471A1 (fr) 1998-06-30 1999-06-28 Derives de n-phenyle-n'-phenylpropilpiperazine et leur procede de preparation

Publications (2)

Publication Number Publication Date
NO20006542D0 true NO20006542D0 (no) 2000-12-21
NO20006542L NO20006542L (no) 2001-02-28

Family

ID=16386265

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006542A NO20006542L (no) 1998-06-30 2000-12-21 N-fenyl-N'-fenylpropylpiperazinderivater og fremgangsmåte for fremstilling derav

Country Status (14)

Country Link
US (1) US6395739B1 (no)
EP (1) EP1090913A4 (no)
KR (1) KR20010053010A (no)
CN (1) CN1307563A (no)
AU (1) AU742720B2 (no)
BR (1) BR9911992A (no)
CA (1) CA2336083A1 (no)
HU (1) HUP0102609A3 (no)
NO (1) NO20006542L (no)
PE (1) PE20001332A1 (no)
PL (1) PL345166A1 (no)
TR (1) TR200003884T2 (no)
WO (1) WO2000000471A1 (no)
ZA (1) ZA200007636B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4117417A1 (de) * 1991-05-28 1992-12-03 Herberts Gmbh Waessrige dispersion eines kathodisch abscheidbaren bindemittels, verfahren zu deren herstellung und deren verwendung
CN1172919C (zh) * 2002-06-03 2004-10-27 上海医药工业研究院 芳烷醇哌嗪衍生物及其在制备抗抑郁症药物中的应用
HUP0700353A2 (en) * 2007-05-18 2008-12-29 Richter Gedeon Nyrt Metabolites of (thio)carbamoyl-cyclohexane derivatives
US20090076043A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched alfuzosin
ATE552002T1 (de) * 2008-02-21 2012-04-15 Richter Gedeon Nyrt Feste zubereitung zur oralen verabreichung
RS53866B1 (en) 2008-07-16 2015-08-31 Richter Gedeon Nyrt. PHARMACEUTICAL FORMULATIONS CONTAINING DOPAMINE RECEPTOR LIGANDS
JP2017214342A (ja) * 2016-06-02 2017-12-07 日清オイリオグループ株式会社 排尿障害の予防用又は改善用組成物
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH449629A (de) 1963-01-23 1968-01-15 Ciba Geigy Verfahren zur Herstellung von Piperazinverbindungen
GB9021535D0 (en) * 1990-10-03 1990-11-14 Wyeth John & Brother Ltd Piperazine derivatives
EP0576766A1 (en) * 1992-06-29 1994-01-05 Novo Nordisk A/S Propanolamine derivatives, their preparation and use
ES2160158T3 (es) * 1994-03-30 2001-11-01 Zeria Pharm Co Ltd Derivados de 4-indol-1-il acido butirico, su preparacion y su utilizacion como inhibidores de receptores alfa1-adrenergicos y testosterona 5alfa-reductasas.

Also Published As

Publication number Publication date
ZA200007636B (en) 2001-07-09
TR200003884T2 (tr) 2001-05-21
CA2336083A1 (en) 2000-01-06
AU742720B2 (en) 2002-01-10
HUP0102609A3 (en) 2002-12-28
PE20001332A1 (es) 2000-12-19
EP1090913A4 (en) 2001-11-07
HUP0102609A2 (hu) 2001-12-28
KR20010053010A (ko) 2001-06-25
BR9911992A (pt) 2001-03-27
AU4290399A (en) 2000-01-17
US6395739B1 (en) 2002-05-28
NO20006542L (no) 2001-02-28
CN1307563A (zh) 2001-08-08
WO2000000471A1 (fr) 2000-01-06
EP1090913A1 (en) 2001-04-11
PL345166A1 (en) 2001-12-03

Similar Documents

Publication Publication Date Title
NO976072L (no) Propiofenonderivater og fremgangsmÕte for fremstilling derav
NO973836L (no) Benzopyran-inneholdende forbindelser og fremgangsmåte for anvendelse derav
NO972248L (no) Funksjonaliserte polyorganosiloksaner og fremgangsmåte for fremstilling derav
CY2013003I1 (el) Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων
NO971485D0 (no) Antineoplastiske kakaoekstrakter, metoder for fremstilling og anvendelse
NO972451D0 (no) 2-heterocyklyloksy og tiometyl-1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og fremgangsmåte for anvendelse derav
NO972249L (no) Funksjonaliserte polyorganosiloksaner og fremgangsmåte for fremstilling derav
NO20012963D0 (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
NO970293D0 (no) Substituerte camptotecinderivater og fremgangsmåte for dens fremstilling
HUP9800555A3 (en) 3,3-diphenylallylamine derivatives and process for their preparation
IL123611A0 (en) Novel amino acid derivatives their preparation and use
IS5942A (is) 3,3-bíarýlpíperidín og 2,2-bíarýlmorfólín afleiður
TR199701051A3 (tr) 2' -Fluoro-5-metil- -l-arabino-furanosilüridin hazirlanma prosesi
NO965023D0 (no) Maltitolblanding og fremstilling derav
IL126839A0 (en) Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation
NO20006542D0 (no) N-fenyl-N'-fenylpropylpiperazinderivater og fremgangsmåte for fremstilling derav
DK0821692T3 (da) Immunopotenserende inosinmonophosphat-5'-nukleotidasemodstandsdygtige derivater og anvendelser deraf
EP0990632A4 (en) ADAMANTANEMETHANOL DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
NO964551D0 (no) Imidazolderivater og fremgangsmåte for fremstilling av slike
NO950959D0 (no) Substituerte N-etyl-glycinderivater for fremstilling av PNA og PNA-/DNA-hybrider
NO960766D0 (no) Nytt protein og fremgangsmåte for fremstilling av dette
NO20012099D0 (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser
NO971419L (no) Fremgangsmåte for fremstilling av 1,3-alkendioler og 3-hydroksyaldehyder
IL129330A (en) Phenoxy-phenylsulfonic acid derivatives and process for their preparation
NO984525D0 (no) Butadienderivater og fremgangsmÕte for fremstilling derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application